Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Rare Disease Data Trust
AddedFeb 16, 2024
UpdatedJun 18, 2026
Rare Disease Data Trust

Rare Disease Data Trust

Rare Disease Data Trust: Accelerating rare disease discovery through patient-centric data monetization partnerships.

HQ
Nashville, TN, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Rare Disease Data Trust, founded with a mission to accelerate the discovery and diagnosis of rare diseases, focuses on patient-centric data monetization. By partnering with community provider health systems, the organization executes targeted searches for undiagnosed rare disease patients, sponsored by bio-pharma companies. Their core services include leveraging lost rare disease patient analytics to facilitate faster and more accurate diagnoses, thereby bridging the gap between healthcare providers and bio-pharma expertise.

Notable affiliations include partnerships with leading bio-pharma companies and community health systems. The organization has achieved significant milestones in improving diagnostic timelines and outcomes for rare disease patients, contributing to enhanced patient care and research advancements. Their impact is evident in the accelerated discovery of rare diseases, fostering a collaborative ecosystem that benefits both patients and the healthcare industry.

Rare Disease Data Trust - Quick Facts

When was Rare Disease Data Trust founded?

Rare Disease Data Trust was founded in 2020.

Where is Rare Disease Data Trust's headquarters located?

Rare Disease Data Trust's headquarters is located in Nashville, TN, US.

When was Rare Disease Data Trust's last funding round?

Rare Disease Data Trust's most recent funding round was for $80k (USD) in July 2022.

How much has Rare Disease Data Trust raised to-date?

As of Jul 21, 2022, Rare Disease Data Trust has raised a total of $710k (USD).

How many employees does Rare Disease Data Trust have?

Rare Disease Data Trust has 10 employees as of Feb 4, 2024.

Rare Disease Data Trust - Classification

Ownership
  • Private
Technology
  • AI
  • Analytics
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Main Product
  • Diagnosis Acceleration
  • Patient-Centric Data Monetization
  • Rare Disease Analytics
  • Targeted Searches
Tags
  • Analytics
  • BioPharma Companies
  • Biotech
  • Consulting
  • Data
  • Healthcare Providers
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 16 more industry codes
NAICS
  • 513200Software Publishers
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 513000Publishing Industries
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 7300Business Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8731Commercial Physical and Biological Research